NCT02647671View on ClinicalTrials.gov

Aquamin and Prevention of Colon Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

March 31, 2021

Study Completion Date

March 31, 2021

Conditions
Colonic Cancer
Interventions
DRUG

Aquamin®

90 days of Aquamin

DRUG

Calcium Carbonate

90 days of Calcium Carbonate

DRUG

Placebo

90 days of placebo

Trial Locations (1)

48109

University of Michigan Hospital, Ann Arbor

All Listed Sponsors
lead

James Varani

OTHER

NCT02647671 - Aquamin and Prevention of Colon Cancer | Biotech Hunter | Biotech Hunter